Recent news on Nimotop

Barr receives approval for generic Nimotop  -  May 8, 2007
SpiritIndia,Nimotop had annual sales of approximately $29 million for the twelve months ended February 2007, based on IMS sales data. Nimotop (nimodipine) is indicated

First-Time Generic Approvals: Ambien, Zoloft, Nimotop  -  May 4, 2007
Medscape (subscription)Pharmaceutical Industries, Inc; brand name Nimotop, Bayer Pharmaceuticals) for improved neurological outcome following subarachnoid hemorrhage (SAH).

Barr Receives Approval for Generic Nimotop(R) Capsules, 30 mg  -  May 2, 2007
PR-Inside.com (Pressemitteilung),Nimotop had annual sales of approximately $29 million for the twelve months ended February 2007, based on IMS sales data. incidence and severity of ischemic

Caraco gets OK to sell generic heart meds  -  Apr 27, 2007
Detroit Free Press,Caraco said the new drug is bioequivalent to Nimotop, a registered trademark of Bayer Pharmaceuticals with US sales of about $26.8 million in 2006.

Generic Nimodipine Approved  -  Apr 25, 2007
Facts and Comparisons,...regardless of their postictus neurological condition (ie, Hunt and Hess grades I to V). The medication is generically equivalent to Nimotop by Bayer.



FDA Announces Nimotop (nimodipine) Boxed Warning to Notify ...  Feb 16, 2006
15, 2006--Bayer and FDA notified healthcare professionals of changes to the prescribing information for nimodipine (Nimotop), including a boxed warning to ... - PharmaLive.com,

FDA Requests Nimodipine (Nimotop) Label Change  Jan 31, 2006
BETHESDA, MD -- January 31, 2006 -- The FDA has requested that Bayer add a boxed warning to the nimodipine (Nimotop) labeling to warn about medication ... - DG News

Alert for Healthcare Professionals Nimodipine (marketed as Nimotop ...  Jan 31, 2006
30, 2006-FDA ALERT [1/2006): The FDA has requested that Bayer add a boxed warning to the nimodipine (Nimotop) labeling to warn about medication administration ... - PharmaLive.com

Bayer: cardiovascular concerns could run deep  Feb 3, 2006
To make matters worse, the FDA recently asked Bayer to add a black-box warning to its stroke drug Nimotop after medication administration errors were found to ... - Pharmaceutical Business Review

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional